Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
伊布地司特治疗进行性多发性硬化症的二期临床试验
期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa1803583
Fox, Robert J; Coffey, Christopher S; Conwit, Robin; Cudkowicz, Merit E; Gleason, Trevis; Goodman, Andrew; Klawiter, Eric C; Matsuda, Kazuko; McGovern, Michelle; Naismith, Robert T; Ashokkumar, Akshata; Barnes, Janel; Ecklund, Dixie; Klingner, Elizabeth; Koepp, Maxine; Long, Jeffrey D; Natarajan, Sneha; Thornell, Brenda; Yankey, Jon; Bermel, Robert A; Debbins, Josef P; Huang, Xuemei; Jagodnik, Patricia; Lowe, Mark J; Nakamura, Kunio; Narayanan, Sridar; Sakaie, Ken E; Thoomukuntla, Bhaskar; Zhou, Xiaopeng; Krieger, Stephen; Alvarez, Enrique; Apperson, Michelle; Bashir, Khurram; Cohen, Bruce A; Coyle, Patricia K; Delgado, Silvia; Dewitt, L Dana; Flores, Angela; Giesser, Barbara S; Goldman, Myla D; Jubelt, Burk; Lava, Neil; Lynch, Sharon G; Moses, Harold; Ontaneda, Daniel; Perumal, Jai S; Racke, Michael; Repovic, Pavle; Riley, Claire S; Severson, Christopher; Shinnar, Shlomo; Suski, Valerie; Weinstock-Guttman, Bianca; Yadav, Vijayshree; Zabeti, Aram